Media Coverage

Stories about new research that found that the risks outweigh the benefits for people who are taking low-dose aspirin to prevent a heart attack or stroke interviews John M. Canty Jr., SUNY Distinguished Professor and Albert and Elizabeth Rekate Professor of medicine and chief of the Division of Cardiovascular Medicine. “No one under the age of 40 should be on aspirin unless there are very unique circumstances,” Canty said.
A $7 million UB-led telemedicine study that can provide lifesaving treatment of Hepatitis C to those recovering from drug addiction has shown such promise that it has been expanded across New York State. “I think you'd want to do both at the same time because the treatment for Hep C in many ways helps substance users get control of their lives,” said Andrew H. Talal, MD, professor of medicine in the Division of  Gastroenterology, Hepatology and Nutrition. “Patients are very happy when they find out that they no longer have to deal with Hep C. It gives them a real benefit on the road to recovery.”
A story about the closing of the geriatric clinic at DeGraff Memorial Hospital quotes Bruce R. Troen, MD, professor of medicine and chief of geriatrics and palliative medicine, who helped oversee the clinic. “We have a dire need for capable and qualified clinicians to take care of older adults,” he said.
Nancy H. Nielsen, MD, PhD, senior associate dean for health policy and clinical professor of medicine, discussed with Newsweek a new health care plan announced by presidential hopeful Kamala Harris. “What she says is no deductibles, no co-pays and out-of-pocket expenses capped at $200. That all sounds wonderful. How do we pay for it?” said Nielsen, who previously served as a senior adviser at the Center for Medicare and Medicaid Innovation under the Obama administration.
Vijay S. Iyer, MD, PhD, associate professor of medicine and chief of the Division of Cardiovascular Medicine, was interviewed for a story about the life-changing impact that transcatheter aortic valve replacement can have for patients with heart disease. “As people get older, valve diseases are pretty common, and we have an aging population,” he said, adding that before 2011, half of those with severe aortic stenosis — or narrowing — weren’t getting treated because the condition is typically a disease of the elderly and many had other serious health conditions that made open chest surgery too risky”
Two Jacobs School of Medicine and Biomedical Sciences faculty members were interviewed for a story on vaccine safety, New York State’s ban on religious exemptions and a lawsuit that has been filed against it. “Of all the medical treatments that we use to prevent and treat disease, vaccines are by far the safest of all interventions,” said Thomas A. Russo, MD, professor of medicine and chief of the Division of Infectious Diseases. He added that there have been more than 10 high-quality studies and an Institute of Medicine panel, all of which found no connection between the measles/mumps/rubella vaccine (MMR) and autism. Dennis Z. Kuo, MD, associate professor of pediatrics and chief of the Division of General Pediatrics, said that resistance against vaccinating children is rooted in fear. “Any fear out there needs to be addressed through rational debate or science,” he said.
Research by Husam A. Ghanim, PhD, research associate professor of medicine, shows that men with type 2 diabetes and suboptimal free testosterone levels experienced an increase in osteoblastic activity with a concomitant increase in bone turnover when assigned to 22 weeks of biweekly intramuscular testosterone injections.
In Good Health, Western New York’s health care newspaper, featured Sanjay Sethi, MD, professor of medicine and chief of the Division of Pulmonary, Critical Care and Sleep Medicine, in its “Meet Your Doctor” column. Sethi discussed the broad range of his research on chronic obstructive pulmonary disease and related diseases.
Thomas A. Russo, MD, professor of medicine and chief of the Division of Infectious Diseases, is interviewed for a story about concerns over the safety of prescription and over-the-counter drugs that are manufactured overseas. “I think that this realization has made us think a little bit about where we stand with our prescription medicines in our new global world and vulnerabilities that exist because of it,” he said. 
An article about medical innovations being developed in Western New York interviews Adnan Siddiqui, MD, PhD, professor of neurosurgery, about the Tigertriever, which can be manipulated while inside a blood vessel to change in size and dimensions, and Anthony D. Martinez, MD, clinical associate professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, who discussed the FibroScan machine, which uses diagnostic imaging that takes about 10 minutes and can replace a more invasive, expensive and risky liver biopsy.
An article details an arthritis drug called Enbrel that seems to significantly cut the risk of developing Alzheimer’s disease, and the decision by the drug’s manufacturer to not develop the drug for this condition because the patent on it will soon expire and the company will not profit from pursuing it further. It reports that in 2016, Richard C. Chou, MD, PhD, associate professor of medicine in the Division of Allergy, Immunology and Rheumatology, and colleagues published an analysis that showed that of 300-odd people with rheumatoid arthritis, those on Enbrel were about a third as likely to get Alzheimer’s as those on other treatments.
A new study suggests that teens with painful chronic illnesses may find YouTube can provide a support network. Young people with chronic pain “feel they cannot engage in the activities they previously enjoyed, or do not want to hold others back knowing they will need to do things more slowly or carefully,” said Alison M. Vargovich, PhD, clinical assistant professor of medicine in the Division of Behavioral Medicine, who was not associated with the study. “As they turn down requests to participate in activities and outings, they become more isolated.” 
A story about $2.4 million in funding for studies at Buffalo’s VA Medical Center reports Jennifer K. Lang, MD, assistant professor of medicine in the Division of Cardiovascular Medicine, will receive $1.4 million to study heart failure and myocardial infarction; and Bruce R. Troen, MD, professor of medicine and chief of geriatrics and palliative medicine, will receive $200,000 to study the impact of high-intensity interval training on older adults.
A story about climate change and the impact it is having on seasonal allergies includes an interview with Stanley A. Schwartz, MD, PhD, UB Distinguished Professor of medicine and pediatrics and chief of the Division of Allergy, Immunology and Rheumatology. “Plants are changing. They’re changing their blooming habits, we're seeing longer periods of time when we have green plants growing, even in a northern climate like this,” he said.
An article about three studies that showed that implantable cardiac devices are underused interviews Anne B. Curtis, MD, Charles and Mary Bauer Professor and chair and SUNY Distinguished Professor in the Department of Medicine. “Device usage across both gender and race was strikingly low, despite medical records documenting patient eligibility for the therapy. The breadth of practice type, from academic medical centers to community hospitals, along with the sheer number of patients highlight the seriousness of the challenge,” she said.